CAS: 1167985-17-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ozoralizumab REF: TM-T77126CAS: 1167985-17-2 | SDS-PAGE:> 95%;SEC-HPLC:95.6% | 306.00 €~2,378.00 € | Tue 10 Dec 24 |
 | Ozoralizumab REF: 3D-CLA1283CAS: 1167985-17-2 | - - - | To inquire | Wed 18 Dec 24 |
Ozoralizumab
CAS:1167985-17-2
Ozoralizumab (ATN-103) is a humanized anti-TNFα antibody and a novel TNFα inhibitor.
Purity:
SDS-PAGE:> 95%;SEC-HPLC:95.6%
Color and Shape:
Liquid
Molecular weight:
38.44 kDa
Ref: TM-T77126
| 1mg | 306.00 € | ||
| 5mg | 782.00 € | ||
| 10mg | 1,184.00 € | ||
| 25mg | 1,762.00 € | ||
| 50mg | 2,378.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ozoralizumab
CAS:1167985-17-2
Trivalent anti-tumour necrosis factor alpha (TNFα) antibody; inflammatory disease treatment
Ref: 3D-CLA1283
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
